Latest Updates

Study

A Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral Hepatic-Directed Vesicle Insulin Add-On to Oral Antidiabetic Treatment in Patients With Type 2 Diabetes Mellitus

February 27, 2014

Share this article
Study

Latest Updates

News

Press Release

Diasome's CMO, Dr. Marc Penn, to Unveil Innovative Diabetes Research at ADA Scientific Sessions

View Article
Study

Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A 6-Month Phase 2b Study in Type 1 Diabetes

View Article
Journal

Could Aiming Insulin at the Liver Be an Answer to Using Less?

View Article
View All